The HORIBA Instruments, Inc. 5390012204 DRI® Cannabinoids calibration and validation solution is designed for use in clinical laboratories and medical facilities. This product plays a crucial role in the calibration and validation of the DRI Cannabinoid Assay, which is used to detect THC in human urine samples. By utilizing this solution, laboratories can ensure the accuracy and reliability of their test results.

This product is an integral component of the DRI Cannabinoid Assay, a diagnostic test used to detect the presence of THC in human urine. The DRI® Cannabinoids solution is specifically designed to provide a known concentration of cannabinoids, allowing laboratories to calibrate and validate their assay results. This process is essential for ensuring the accuracy and reliability of the test results, which is critical in various medical and legal applications.

Key Features

• Calibration and validation solution for the DRI Cannabinoid Assay
• Designed to detect THC in human urine samples
• Provides a known concentration of cannabinoids (50ng)
• Ensures accuracy and reliability of test results
• Crucial for medical and legal applications where THC detection is required
• Supports in vitro diagnostic testing
• Available in a 5 mL volume, packaged in a single box

Product Specifications

Ideal For